SSA
ASTH icon

Schonfeld Strategic Advisors’s Astrana Health ASTH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,627
Closed -$309K – 2488
2024
Q2 		$309K Buy
7,627
+842
+12% +$33.4K ﹤0.01% 1676
2024
Q1 		$285K Buy
+6,785
New +$265K ﹤0.01% 1670
2023
Q1 		– Sell
-32,081
Closed -$949K – 2739
2022
Q4 		$949K Buy
32,081
+6,061
+23% +$195K 0.01% 1176
2022
Q3 		$1.01M Buy
+26,020
New +$1.19M 0.01% 1250

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Schonfeld Strategic Advisors's ASTH Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of Astrana Health (ASTH) in Q3 2024, closing a stake of 7,627 shares — an estimated $309K sold.

Schonfeld Strategic Advisors first reported a position in ASTH in Q3 2022 and held it in 4 quarters. The position peaked at $1.01M in Q3 2022. 189 funds tracked by Wall St. Rank hold ASTH as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining Astrana Health position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 7,627 Astrana Health shares in Q3 2024, an estimated $309K.
  • Schonfeld Strategic Advisors first reported a position in Astrana Health in Q3 2022 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Astrana Health position peaked at $1.01M in Q3 2022.
  • 189 funds tracked by Wall St. Rank held Astrana Health as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.